×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month
clinical
1,247 words
KG: A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Op... (NCT03887455)
2026-03-22
kind:clinical-trial
section:clinical-trials
state:published
Contents
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Op... (NCT03887455)
Knowledge Graph
Related Hypotheses (13)
Multi-Modal CRISPR Platform for Simultaneous Editing and Mon
Score: 0.42
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
APOE Isoform Conversion Therapy
Score: 0.44
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.41
Show 8 more
Related Analyses (4)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Related Experiments (1)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
See Also (15)
Section 147: Telehealth and Remote Monitoring in CBS/PS
therapeutic · Pages share 6 hypotheses
Integrated Stress Response Modulator Therapy in Neurode
therapeutic · Pages share 6 hypotheses
Neurodegeneration
disease · Pages share 6 hypotheses
ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 6 hypotheses
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 5 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Therapeutic Modalities in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Trace Amine-Associated Receptor (TAAR) Modulator Therap
therapeutic · Pages share 5 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 5 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 5 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapies for
therapeutic · Pages share 5 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 5 hypotheses
S100 Protein (S100A8/A9/A12) Modulator Therapy for Neur
therapeutic · Pages share 5 hypotheses
RNA Targeting Therapy for Neurodegeneration
therapeutic · Pages share 5 hypotheses
Show 10 more
Knowledge Graph (1 edges)
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Op... (NCT03887455)
references
APOE